UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-A

 

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

 

Medical Transcription Billing, Corp.
(Exact name of registrant as specified in its charter)

 

 

 

Delaware 22-3832302
(State of incorporation or organization) (I.R.S. Employer Identification No.)

 

7 Clyde Road

Somerset, New Jersey 08873

(Address of principal executive offices and zip code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class Name of each exchange on which
to be so registered each class is to be registered
Common Stock, par value $0.001 per share The Nasdaq Stock Market, LLC

 

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨

 

Securities Act registration statement file number to which this form relates: 333-192989

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

1
 

 

Item 1. Description of Registrant’s Securities to be Registered

 

For a description of the securities of Medical Transcription Billing, Corp. (the “Registrant”) being registered hereunder, reference is made to the information set forth under the heading “Description of Capital Stock” contained in the Registrant’s registration statement on Form S-1 (File No. 333-192989), as initially filed with the Securities and Exchange Commission (the “Commission”) on December 20, 2013, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits

 

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market, LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2
 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: July 2, 2014 MEDICAL TRANSCRIPTION BILLING, CORP.
     
     
  By: /s/ Mahmud Haq  
    Mahmud Haq
    Chairman of the Board and Chief Executive Officer

 

 

 

 

 

 

3